Cognetivity Neurosciences Ltd.
CGNSF · OTC
10/31/2023 | 7/31/2023 | 4/30/2023 | 1/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 43.7% | 387% | -90.8% | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | -1,547.3% | 62.5% | -64.5% | 89.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,401.9% | -3,703.9% | -23,270.9% | -3,317.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -6,985.2% | -9,538.9% | -50,592.6% | -5,652.4% |
| EPS Diluted | -0.023 | -0.022 | -0.025 | -0.03 |
| % Growth | -3.6% | 9.8% | 18.5% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |